Thanks to an R35 grant from the National Institutes of Health (NIH), associate professor Emily Day and her research group will continue their innovative research on designing, characterizing and using unique nanoparticles to manage diseases.
CRiSP Faculty, Emily Day receives NIH R35 grant
